Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

    Funding opportunity for cancer research innovations in statistical methods, epidemiology, survivorship, behaviors, healthcare, and implementation.

    Browse similar grants
    Cancer Research Grants 2026Public Health Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/resubmission/revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/resubmission/revision) | January 7, 2028 (Closing)

    Funding Amounts: Up to $250,000 in direct costs annually, excluding consortium F&A costs, for up to 5 years

    Summary: Supports cancer control and population sciences research advancing methods, epidemiology, behavior, healthcare delivery, survivorship, digital health, and implementation science.

    Key Information: Basic cancer biology and development of novel cancer diagnostics or therapies are not responsive and will not be reviewed.


    Description

    The National Cancer Institute (NCI), through its Division of Cancer Control and Population Sciences (DCCPS), supports R01 research on novel scientific ideas with potential to substantially advance cancer control and population sciences. The program emphasizes scientific challenges suited to reduced budgets and shorter time spans, while encouraging early-stage investigators and expanding their participation in the R01 portfolio. Applications may propose clinical trials, but trials are not required.

    The research scope includes statistical and analytic methods, cancer surveillance informatics, environmental and genomic epidemiology, systems modeling, behavioral research, healthcare delivery, cancer survivorship, digital health and data science, and implementation science. DCCPS seeks to reduce cancer risk, incidence, and deaths and improve survivors’ quality of life through research on cancer causes and distribution, effective interventions, and cancer trends across populations.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.